Search Results - "Nacak, Tanju"
-
1
An ancient Wnt-Dickkopf antagonism in Hydra
Published in Development (Cambridge) (01-03-2006)“…The dickkopf ( dkk ) gene family encodes secreted antagonists of Wnt signalling proteins, which have important functions in the control of cell fate,…”
Get full text
Journal Article -
2
The BTB-kelch Protein LZTR-1 Is a Novel Golgi Protein That Is Degraded upon Induction of Apoptosis
Published in The Journal of biological chemistry (24-02-2006)“…Members of the BTB-kelch superfamily play important roles during fundamental cellular processes, such as the regulation of cell morphology, migration, and gene…”
Get full text
Journal Article -
3
The BTB-Kelch Protein KLEIP Controls Endothelial Migration and Sprouting Angiogenesis
Published in Circulation research (27-04-2007)“…Sprouting and invasive migration of endothelial cells are important steps of the angiogenic cascade. Vascular endothelial growth factor (VEGF) induces…”
Get full text
Journal Article -
4
Su1916 RAPID HISTO-ENDOSCOPIC MUCOSAL HEALING WITH (HIGH DOSE) MESALAMINE IN ACTIVE MILD-MODERATE ULCERATIVE COLITIS: POSTHOC ANALYSIS OF POOLED DATA FROM 4 DOUBLE-BLIND, DOUBLE-DUMMY, MULTICENTER, RANDOMIZED TRIALS
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2020)Get full text
Journal Article -
5
Mesalazine granules promote disease clearance in patients with mild-to-moderate ulcerative colitis
Published in United European gastroenterology journal (01-10-2023)“…Over the past decade, treatment targets for ulcerative colitis (UC) have become more stringent, incorporating multiple parameters. Recently, the concept of…”
Get full text
Journal Article -
6
-
7
-
8
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis
Published in Gastroenterology (New York, N.Y. 1943) (01-12-2018)“…Lymphocytic colitis is a common cause of chronic, nonbloody diarrhea. However, the effects of treatment are unclear and randomized placebo-controlled trials…”
Get full text
Journal Article -
9
Distribution of histopathological features along the colon in microscopic colitis
Published in International journal of colorectal disease (2021)“…Purpose The diagnosis microscopic colitis (MC) consisting of collagenous colitis (CC) and lymphocytic colitis (LC) relies on histological assessment of mucosal…”
Get full text
Journal Article -
10
1 - A Novel Multi-Matrix Formulation of the Broad-Spectrum, Poorly Absorbed Antibiotic Rifamycin SV is Equally Effective as Systemic Ciprofloxacin in the Oral Treatment of Travelers' Diarrhea: a Double-Blind, Double-Dummy, Multicentre, Randomized Study
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2017)Get full text
Journal Article -
11
Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria
Published in Journal of travel medicine (2018)“…The novel oral antibiotic formulation Rifamycin SV-MMX®, with a targeted delivery to the distal small bowel and colon, was superior to placebo in treating…”
Get full text
Journal Article -
12
A Novel Multi-Matrix Formulation of the Broad-Spectrum, Poorly Absorbed Antibiotic Rifamycin SV is Equally Effective as Systemic Ciprofloxacin in the Oral Treatment of Travelers' Diarrhea: a Double-Blind, Double-Dummy, Multicentre, Randomized Study
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2017)Get full text
Journal Article -
13
Sa1760 - Novel Microscopic Colitis Disease Activity Index Reflects High Efficacy of Oral Once Daily Budesonide Treatment in Lymphocytic Colitis: Post-HOC Analysis of a Randomized, Double-Blind, Double-Dummy, Multicenter, Trial
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2018)Get full text
Journal Article -
14
-
15
Efficacy and safety of prolonged release budesonide granules in mesalazine-refractory ulcerative colitis: A multi-centre Phase IIa study (TOPICAL-1)
Published in United European gastroenterology journal (01-12-2020)“…Background In patients with mesalazine-refractory ulcerative colitis, systemic corticosteroids are the treatment of choice. Objective To evaluate the efficacy…”
Get full text
Journal Article -
16
Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial
Published in United European gastroenterology journal (01-02-2018)“…Background Adherence to mesalazine treatment is essential for the successful treatment of ulcerative colitis. Objective The objective of this study was to…”
Get full text
Journal Article